Weight‑loss injections reshape holiday retreats as operators adapt services

Weight‑loss injections such as Mounjaro and Ozempic are reshaping the market for slimming holidays as retreats and medical spas adapt programmes to support guests already taking the drugs rather than compete with them.

Operators across the price spectrum report growing demand for services tailored to people on GLP‑1 and GIP‑targeting medications. Some retreats have added bolt‑on packages, medically supervised programmes or personalised nutrition and training to complement the injections, while a smaller number of clinics prescribe the drugs in medically indicated cases.

Industry figures and clinicians say the changes are practical rather than terminal for the sector: the injections have not killed demand for weight‑loss holidays, but have altered what travellers seek. Juls Abernethy, co‑founder of The Body Retreat, which has operated programmes in the West Country for 15 years, said lower‑end offers and flash sales are evidence of a market pivot. "Six months of jabs could cost as little as £700 at present. Little effort, less outlay – it seems like the ultimate weight‑loss magic wand," she said, noting that many retreats now provide support for those already using the medications.

Luxury operators report no obvious downturn. Frances Geoghegan of Healing Holidays said high‑end spas remain busy and are developing exclusive programmes for guests on injections. Trend forecasters at Stylus have predicted the so‑called "Ozempic effect" will be a key influence on luxury travel, with a rise in retreats that explicitly support people using the injections.

Medical teams at retreats emphasise that the drugs are not a standalone solution and that appropriate nutrition and exercise are important while patients are taking them. Pharmaceutical companies and clinicians warn that some of the weight loss can include lean muscle: "It’s vital to eat properly and exercise while you’re on these drugs," Abernethy said. "The pharmaceutical companies themselves estimate up to a third of weight lost will be muscle mass — because most people under eat, under nourish and the body ends up using muscle as fuel. Losing lean muscle is a disaster."

Clinics that take a pragmatic approach work to manage side effects and to preserve metabolic and musculoskeletal health. Amanda Overeynder, a dietitian and senior health coach at Combe Grove Metabolic Health Centre in Bath, said the injections can be useful for patients who struggle with what she called "food noise and food addiction," but that tailored food plans and gradual reintroduction of movement are central to safe outcomes. At medically oriented centres such as Pritikin Longevity Center in Miami and Original Mayr Medical Resort in Austria, staff report guests arriving already on medication and focus on minimising adverse effects while preserving lean mass. "In any given week, it’s not uncommon for 10–15 per cent of our guests to arrive using one of these medications," said Dr. Marianela Areces, medical director at Pritikin.

Not all facilities prescribe the injections. Mayrlife in Austria, which uses Mayr medicine principles, and several other clinics say they do not provide or administer weight‑loss injections, instead offering diagnostics and individually tailored lifestyle plans. Original Mayr’s head physician, Dr. Ursula Muntean‑Rock, said the centre will prescribe injections only when there is a clear medical indication.

A range of retreat formats has emerged. The Body Retreat offers a short, small‑group programme with online follow‑up and a bolt‑on package for people on injections, while Combe Grove markets metabolic health retreats emphasising high‑protein, low‑carbohydrate meals and gradual physical activity. High‑end centres such as Lanserhof Lans in Austria and Euphoria Retreat in Greece offer comprehensive diagnostics and personalised training aimed at "enhancing the benefits of weight‑loss drugs," according to programme descriptions. Prices vary widely: multi‑day medically focused packages can range from about £1,200 for brief metabolic breaks to more than £6,000 for exclusive semaglutide management and advanced weight‑loss programmes.

Retreat doctors and travel advisers also offer practical guidance for guests transporting injectable medications. Most guidance recommends storing medication between 2°C and 8°C, noting that many formulations remain safe at room temperature for 21 to 28 days. Travellers are advised to pack injections in carry‑on luggage to avoid temperature extremes in cargo holds, keep original packaging and carry a copy of the prescription.

Clinicians and operators caution that the science and market are developing rapidly, and that regulation and safety oversight can lag behind. "It’s moving so fast, it’s hard to keep up," Abernethy said, adding that she is concerned about the ability of regulation and safety standards to match the pace of change.

Some centres are tailoring programmes for people who want to taper off medications. Pritikin, for example, incorporates strategies to help guests manage side effects and to preserve muscle mass while reducing reliance on injections. Other retreats, including Ananda in the Himalayas, integrate psychosocial therapies such as yoga, breathwork and counselling to address drivers of overeating that clinicians say are not purely physiological. Dr. Sreelal Sankar, head of Ayurveda at Ananda, said overeating often stems from emotional factors rather than physical hunger and that holistic therapies can be part of a sustained approach.

As new medications and clinical data emerge, retreat operators and medical directors say they will continue to adapt programmes. For now, the injections are changing client expectations and prompting a diversification of services across the weight‑loss holiday market, from pragmatic metabolic resets to high‑end medically supervised packages that sit alongside traditional lifestyle and holistic offerings.